C21 Investments Inc.

CWLXF ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018 FY2017
Assets
Cash & Equivalents $209.2K $66
Accounts Receivable $12.1K $4.4K
Inventory $0 $0
Total Current Assets $231.1K $4.4K
Property, Plant & Equipment — —
Goodwill $0 —
Intangible Assets (Excl. Goodwill) — —
Total Assets $279.6K $49.7K
Liabilities
Accounts Payable $152.2K $351.4K
Total Current Liabilities $152.2K $351.4K
Long-Term Debt — —
Total Liabilities $209.4K $405.3K
Stockholders' Equity
Retained Earnings $-14.4M $-13.8M
Total Stockholders' Equity $70.2K $-355.6K
← Newer Page 2 of 2 Older →